Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045, India
The global extracorporeal membrane oxygenation machine market size stood at US$ 531 Million in 2021 and is expected to grow at a steady CAGR of 5% during the forecast period from 2022 to 2032, reaching a valuation of US$ 908 Billion by the end of 2032.
The rising adoption of extracorporeal membrane oxygenation machines is attributed to the increasing prevalence of chronic diseases and rapid growth in organ transplantation procedures worldwide.
Data Points | Market Insights |
---|---|
Extracorporeal Membrane Oxygenation Machine Market Value 2022 | US$ 531 Million |
Extracorporeal Membrane Oxygenation Machine Market Value 2026 | US$ 673 Million |
Extracorporeal Membrane Oxygenation Machine Market Projected Value 2032 | US$ 908 Million |
Extracorporeal Membrane Oxygenation Machine Market Forecast CAGR (2022 to 2032) | 5% |
Key Players | Medtronic plc (USA), Fresenius Medical Care A.G. & Co. KGAA (Germany), Getinge Group (Sweden), Microport (China), Origin Biomedical (USA), Terumo Cardiovascular Systems Corporation, Livanova plc (United Kingdom), Nipro Corporation (Japan), Euro sets S.R.L. (Italy), Cytosorbents Corporation (Australia), and Abiomed. |
Rising complications during surgical procedures like heart transplants have prompted medical professionals to adopt innovative devices like extracorporeal membrane oxygenation machines in healthcare settings.
Extracorporeal membrane oxygenation machines are advanced medical devices used to provide prolonged cardiac and respiratory support to persons whose hearts and lungs are unable to function properly. They have become ideal tools used in the care of adults and children with severe cardiac and pulmonary dysfunction.
These machines are mostly used when all the other medical options prove ineffective for patients whose lungs can’t provide enough oxygen to their body or can’t get rid of carbon dioxide. ECMO machines can also be used for patients undergoing heart or lung transplants.
The increasing prevalence of chronic diseases coupled with a rapid surge in heart and lung transplants is emerging as a key factor in boosting the sales of extracorporeal membrane oxygenation machines and the trend is likely to escalate during the forecast period.
Leading extracorporeal oxygenation machine manufacturers are continuously innovating to develop advanced products that can help end users effectively treat patients with heart or lung failures. For instance, in 2020, INTEGRIS Health and EMSA unveiled a one-of-a-kind specialty care ECMO ambulance.
Advancements in lung pulmonary airway disease treatment, the presence of favorable reimbursement policies, and the expansion of the healthcare industry across developing regions of Asia and Africa will further expand the extracorporeal membrane oxygenation machine market size during the forthcoming years.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global demand for extracorporeal membrane oxygenation machines is anticipated to grow at a moderate CAGR of 5% during the forecast period between 2022 and 2032. Growth in the market is driven by the rising prevalence of cardiovascular and respiratory diseases, the growing adoption of ECMO in lung and heart transplantation procedures, an increase in the number of ECMO centers, and advancements in extracorporeal membrane oxygenation machines.
Extracorporeal membrane oxygenation has become one of the most widely used techniques for providing effective circulation and respiratory support in critically ill patients. It has emerged as an ideal alternative to cardiopulmonary bypass (CPB) used during organ transplantation procedures.
The increasing prevalence of chronic diseases such as COPD and along with the rise in the number of heart and lung transplantation procedures being performed is providing a major impetus to the extracorporeal membrane oxygenation machine market growth.
As per the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) was the third leading cause of death worldwide in 2019, causing around 3.23 million deaths. This rise in the mortality rate of respiratory and cardiovascular diseases will continue to expand the extracorporeal membrane oxygenation machine market size during the forthcoming years.
Similarly, the growing geriatric population and favorable government laws, investments, and initiatives are creating growth avenues within the global extracorporeal membrane oxygenation machine market.
ECMO machines offer various benefits such as higher speed and short processing times which is fueling their adoption across various end-use verticals such as intensive care units, operating rooms, cardiac catheterization labs, and emergency departments.
The outbreak of COVID-19 created new opportunities for ECMO equipment manufacturers during the last few years. They become essential tools for improving the survival chances of severe COVID-19 patients.
What are the Challenges Faced by the Extracorporeal Membrane Oxygenation Machine Market?
There is no doubt that sales of extracorporeal membrane oxygenation machines are gathering huge across end-use verticals. However, there are various factors that are slowing down the growth of the extracorporeal membrane oxygenation machine market.
Some of these factors are the increasing extracorporeal membrane oxygenation machine prices due to frequent advancements, scarcity of qualified professionals, and low availability of these devices in some regions.
Rise in Organ Transplantation Procedures Augmenting Demand for ECMO Machines in the USA
As per FMI, the USA will continue to remain the most lucrative market for extracorporeal membrane oxygenation machines during the forecast period, owing to the rapidly developing healthcare sector, rising adoption of advanced technologies, the surge in the number of lung cancer surgeries performed, the heavy presence of leading medical device manufacturers, favorable government support, and increasing prevalence of chronic diseases.
The United States has one of the most developed and sophisticated healthcare industries in the world. Both government and non-government organizations are putting efforts to make advanced medical technologies available to healthcare professionals across the country. This will continue to generate lucrative opportunities for ECMO machine manufacturers during the forecast period.
Similarly, a sharp rise in the number of organ transplants is fueling the adoption of ECMO machines in the country. According to the Health Resource and Service Administration (HRSA), the number of heart transplants performed in adults alone rose to 3715 in 2020.
Rise in Organ Transplantation Procedures Creating Demand for ECMO Machines in Japan
In recent years, demand for ECMO machines has risen at a significant pace across Japan and this trend is likely to continue during the forecast period, owing to the rising geriatric population, increasing healthcare spending, surge in chronic disease cases, booming organ transplant market, favorable government initiatives, and availability of advanced medical technologies.
Demand for ECMO Machines to Remain High Throughout the Forecast Period
By product, the global extracorporeal membrane oxygenation machine market has been segmented into ECMO machines and software. Among these, the ECMO machines segment dominated the extracorporeal membrane oxygenation machine market in 2021 and is forecast to grow at a relatively higher CAGR over the assessment period.
Factors such as the growing popularity of portable ECMO devices, the booming healthcare industry, and the expansion of the portable medical devices market are favoring the growth of this segment.
FMI’s latest extracorporeal membrane oxygenation machine market forecast indicates that demand for portable ECMO machines will rise at a substantial pace amid the rising adoption of homecare medical devices across developed and developing regions.
Application Segment to Account for Majority of Revenue Share
Based on service type, the extracorporeal membrane oxygenation machine market is segmented into application, middleware, and infrastructure. Among these, the application segment leads the market growth, accounting for the bulk of the revenue share generated in the market. The rising frequency of target diseases, increasing sales of ECMO machines, and technological improvements in ECMO machines contribute to the growth of this segment.
Sales of Controllers to Continue Rising in the Extracorporeal Membrane Oxygenation Machine Market
As per FMI, the controller's segment is expected to dominate the extracorporeal membrane oxygenation machine market during the projected period. The rising adoption of controllers by end-users is a major factor triggering the growth of this segment.
Arterio-Venous Remains the Most Preferred Modality Type
The latestextracorporeal membrane oxygenation machine market trends reveal that the arterio-venous segment will continue to lead the global extracorporeal membrane oxygenation machine market during the forecast period, owing to the various benefits such as highly effective nature and better medical evaluation associated with this technology.
Leading extracorporeal membrane oxygenation machine manufacturers are constantly focusing on new product launches and approvals for expanding their product portfolios. Besides this, they have adopted growth strategies such as partnerships, acquisitions, mergers, joint ventures, and collaborations to gain a competitive edge in the global extracorporeal membrane oxygenation machine market.
For instance:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
FMI’s latest market survey uncovers key investment pockets within the extracorporeal membrane oxygenation machine market. It analyses how key extracorporeal membrane oxygenation machine manufacturers are innovating to meet end-user demands.
The study provides inclusive details about the extracorporeal membrane oxygenation machine ecosystem and highlights key market governing factors such as growth drivers, restraints, and emerging opportunities. Besides this, it discusses in detail the latest extracorporeal membrane oxygenation machine market trends.
FMI also offers exhaustive research into factors pushing demand for extracorporeal membrane oxygenation machines across developed and developing regions. It attempts to explore the growth potential of regions with a high patient pool and explain how advancements in medical device technologies are affecting extracorporeal membrane oxygenation machine sales.
Want to get a comprehensive assessment of the extracorporeal membrane oxygenation machine market and much more Keep in touch with Future Market Insights, one of the leading research companies in the world.
The Extracorporeal Membrane Oxygenation Machine Market analysis includes:
Attribute | Details |
---|---|
Forecast Period | 2022 to 2032 |
Historic Data Available for | 2015 to 2021 |
Market Analysis | US$ Million for Value |
Report Coverage | Market forecast, company share analysis, competition intelligence, Drivers, Restraints, Opportunities and Threats analysis, market dynamics and challenges, and strategic growth initiatives |
Key Segments Covered | By product, By Service Type, By Component, By Modality, By Patient Type, By Region |
Key regions covered | North America
|
Patient Type |
|
Key companies profiled | Medtronic plc (USA), Fresenius Medical Care A.G. & Co. KGAA (Germany), Getinge Group (Sweden), Microport (China), Origin Biomedical (USA), Terumo Cardiovascular Systems Corporation, Livanova plc (United Kingdom), Nipro Corporation (Japan), Euro sets S.R.L. (Italy), Cytosorbents Corporation (Australia), and Abiomed. |
Customization & pricing | Available upon request |
1. Executive Summary | Extracorporeal Membrane Oxygenation Machine Market 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. FMI Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Demand 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Million) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background 4.1. Market, by Key Countries 4.2. Market Opportunity Assessment (US$ Million) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in Optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Growth in Automation, By Country 4.5.3. Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2015 to 2021 and Forecast, 2022 to 2032 6.1. Historical Market Analysis, 2015 to 2021 6.2. Current and Future Market Projections, 2022 to 2032 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2015 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Value (US$ Million) Analysis, 2015 to 2021 7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Component 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Million) and Analysis By Component, 2015 to 2021 8.3. Current and Future Market Value (US$ Million) and Analysis and Forecast By Component, 2022 to 2032 8.3.1. Pumps 8.3.2. Oxygenators 8.3.3. Controllers 8.3.4. Cannul 8.3.5. Accessories 8.4. Market Attractiveness Analysis By Component 9. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Million) and Analysis By Product, 2015 to 2021 9.3. Current and Future Market Value (US$ Million) and Analysis and Forecast By Product, 2022 to 2032 9.3.1. ECMO Machines 9.3.1.1. Portable Devices 9.3.1.2. Static Devices 9.3.2. Software 9.4. Market Attractiveness Analysis By Product 10. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Provider 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Million) and AnalysisBy Provider, 2015 to 2021 10.3. Current and Future Market Value (US$ Million) and Analysis and ForecastBy Provider, 2022 to 2032 10.3.1. Application 10.3.2. Middleware 10.3.3. Infrastructure 10.4. Market Attractiveness AnalysisBy Provider 11. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Modality 11.1. Introduction / Key Findings 11.2. Historical Market Value (US$ Million) and Analysis By Modality, 2015 to 2021 11.3. Current and Future Market Value (US$ Million) and Analysis and Forecast By Modality, 2022 to 2032 11.3.1. Veno-Venous 11.3.2. Veno-Arterials 11.3.3. Arterio-Venous 11.4. Market Attractiveness Analysis By Modality 12. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Patient Type 12.1. Introduction / Key Findings 12.2. Historical Market Value (US$ Million) and Analysis By Patient Type, 2015 to 2021 12.3. Current and Future Market Value (US$ Million) and Analysis and Forecast By Patient Type, 2022 to 2032 12.3.1. Neonates 12.3.2. Pediatrics 12.3.3. Adults 12.4. Market Attractiveness Analysis By Patient Type 13. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Region 13.1. Introduction 13.2. Historical Market Value (US$ Million) and Analysis By Region, 2015 to 2021 13.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2022 to 2032 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. Asia Pacific 13.3.5. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Value (US$ Million) and Trend Analysis By Market Taxonomy, 2015 to 2021 14.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 14.4.1. By Country 14.4.1.1. USA 14.4.1.2. Canada 14.4.1.3. Rest of North America 14.4.2. By Provider 14.4.3. By Component 14.4.4. By Product 14.4.5. By Modality 14.4.6. By Patient Type 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Provider 14.5.3. By Component 14.5.4. By Product 14.5.5. By Modality 14.5.6. By Patient Type 15. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Value (US$ Million) and Trend Analysis By Market Taxonomy, 2015 to 2021 15.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 15.4.1. By Country 15.4.1.1. Brazil 15.4.1.2. Mexico 15.4.1.3. Rest of Latin America 15.4.2. By Provider 15.4.3. By Component 15.4.4. By Product 15.4.5. By Modality 15.4.6. By Patient Type 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Provider 15.5.3. By Component 15.5.4. By Product 15.5.5. By Modality 15.5.6. By Patient Type 16. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Value (US$ Million) and Trend Analysis By Market Taxonomy, 2015 to 2021 16.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 16.4.1. By Country 16.4.1.1. Germany 16.4.1.2. France 16.4.1.3. United Kingdom 16.4.1.4. Italy 16.4.1.5. Russia 16.4.1.6. Rest of Europe 16.4.2. By Provider 16.4.3. By Component 16.4.4. By Product 16.4.5. By Modality 16.4.6. By Patient Type 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Provider 16.5.3. By Component 16.5.4. By Product 16.5.5. By Modality 16.5.6. By Patient Type 17. Asia Pacific Market Analysis 2015 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Value (US$ Million) and Trend Analysis By Market Taxonomy, 2015 to 2021 17.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 17.4.1. By Country 17.4.1.1. China 17.4.1.2. Japan 17.4.1.3. South Korea 17.4.1.4. Rest of Asia Pacific 17.4.2. By Provider 17.4.3. By Component 17.4.4. By Product 17.4.5. By Modality 17.4.6. By Patient Type 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Provider 17.5.3. By Component 17.5.4. By Product 17.5.5. By Modality 17.5.6. By Patient Type 18. Middle East and Africa Market Analysis 2015 to 2021 and Forecast 2022 to 2032 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Value (US$ Million) and Trend Analysis By Market Taxonomy, 2015 to 2021 18.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 18.4.1. By Country 18.4.1.1. GCC Countries 18.4.1.2. South Africa 18.4.1.3. Turkey 18.4.1.4. Rest of Middle East and Africa 18.4.2. By Provider 18.4.3. By Component 18.4.4. By Product 18.4.5. By Modality 18.4.6. By Patient Type 18.5. Market Attractiveness Analysis 18.5.1. By Country 18.5.2. By Provider 18.5.3. By Component 18.5.4. By Product 18.5.5. By Modality 18.5.6. By Patient Type 19. Key Countries Market Analysis 2015 to 2021 and Forecast 2022 to 2032 19.1. Introduction 19.1.1. Market Value Proportion Analysis, By Key Countries 19.1.2. Global Vs. Country Growth Comparison 19.2. USA Market Analysis 19.2.1. Value Proportion Analysis by Market Taxonomy 19.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 19.2.2.1. By Provider 19.2.2.2. By Component 19.2.2.3. By Product 19.2.2.4. By Modality 19.2.2.5. By Patient Type 19.3. Canada Market Analysis 19.3.1. Value Proportion Analysis by Market Taxonomy 19.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 19.3.2.1. By Provider 19.3.2.2. By Component 19.3.2.3. By Product 19.3.2.4. By Modality 19.3.2.5. By Patient Type 19.4. Mexico Market Analysis 19.4.1. Value Proportion Analysis by Market Taxonomy 19.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 19.4.2.1. By Provider 19.4.2.2. By Component 19.4.2.3. By Product 19.4.2.4. By Modality 19.4.2.5. By Patient Type 19.5. Brazil Market Analysis 19.5.1. Value Proportion Analysis by Market Taxonomy 19.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 19.5.2.1. By Provider 19.5.2.2. By Component 19.5.2.3. By Product 19.5.2.4. By Modality 19.5.2.5. By Patient Type 19.6. Germany Market Analysis 19.6.1. Value Proportion Analysis by Market Taxonomy 19.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 19.6.2.1. By Provider 19.6.2.2. By Component 19.6.2.3. By Product 19.6.2.4. By Modality 19.6.2.5. By Patient Type 19.7. France Market Analysis 19.7.1. Value Proportion Analysis by Market Taxonomy 19.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 19.7.2.1. By Provider 19.7.2.2. By Component 19.7.2.3. By Product 19.7.2.4. By Modality 19.7.2.5. By Patient Type 19.8. Italy Market Analysis 19.8.1. Value Proportion Analysis by Market Taxonomy 19.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 19.8.2.1. By Provider 19.8.2.2. By Component 19.8.2.3. By Product 19.8.2.4. By Modality 19.8.2.5. By Patient Type 19.9. Russia Market Analysis 19.9.1. Value Proportion Analysis by Market Taxonomy 19.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 19.9.2.1. By Provider 19.9.2.2. By Component 19.9.2.3. By Product 19.9.2.4. By Modality 19.9.2.5. By Patient Type 19.10. United Kingdom Market Analysis 19.10.1. Value Proportion Analysis by Market Taxonomy 19.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 19.10.2.1. By Provider 19.10.2.2. By Component 19.10.2.3. By Product 19.10.2.4. By Modality 19.10.2.5. By Patient Type 19.11. China Market Analysis 19.11.1. Value Proportion Analysis by Market Taxonomy 19.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 19.11.2.1. By Provider 19.11.2.2. By Component 19.11.2.3. By Product 19.11.2.4. By Modality 19.11.2.5. By Patient Type 19.12. Japan Market Analysis 19.12.1. Value Proportion Analysis by Market Taxonomy 19.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 19.12.2.1. By Provider 19.12.2.2. By Component 19.12.2.3. By Product 19.12.2.4. By Modality 19.12.2.5. By Patient Type 19.13. South Korea Market Analysis 19.13.1. Value Proportion Analysis by Market Taxonomy 19.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 19.13.2.1. By Provider 19.13.2.2. By Component 19.13.2.3. By Product 19.13.2.4. By Modality 19.13.2.5. By Patient Type 19.14. GCC Countries Market Analysis 19.14.1. Value Proportion Analysis by Market Taxonomy 19.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 19.14.2.1. By Provider 19.14.2.2. By Component 19.14.2.3. By Product 19.14.2.4. By Modality 19.14.2.5. By Patient Type 19.15. South Africa Market Analysis 19.15.1. Value Proportion Analysis by Market Taxonomy 19.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 19.15.2.1. By Provider 19.15.2.2. By Component 19.15.2.3. By Product 19.15.2.4. By Modality 19.15.2.5. By Patient Type 19.16. Turkey Market Analysis 19.16.1. Value Proportion Analysis by Market Taxonomy 19.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 19.16.2.1. By Provider 19.16.2.2. By Component 19.16.2.3. By Product 19.16.2.4. By Modality 19.16.2.5. By Patient Type 19.16.3. Competition Landscape and Player Concentration in the Country 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Concentration 20.3. Market Share Analysis of Top Players 20.4. Market Presence Analysis 20.4.1. By Regional Footprint of Players 20.4.2. Product Footprint by Players 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Benchmarking 21.3. Competition Deep Dive 21.3.1. FRESENIUS MEDICAL CARE 21.3.1.1. Overview 21.3.1.2. Product Portfolio 21.3.1.3. Sales Footprint 21.3.1.4. Strategy Overview 21.3.2. GETINGE GROUP 21.3.2.1. Overview 21.3.2.2. Product Portfolio 21.3.2.3. Sales Footprint 21.3.2.4. Strategy Overview 21.3.3. MEDTRONIC PLC 21.3.3.1. Overview 21.3.3.2. Product Portfolio 21.3.3.3. Sales Footprint 21.3.3.4. Strategy Overview 21.3.4. MICROPORT 21.3.4.1. Overview 21.3.4.2. Product Portfolio 21.3.4.3. Sales Footprint 21.3.4.4. Strategy Overview 21.3.5. TERUMO CARDIOVASCULAR SYSTEMS CORPORATION 21.3.5.1. Overview 21.3.5.2. Product Portfolio 21.3.5.3. Sales Footprint 21.3.5.4. Strategy Overview 21.3.6. NIPRO CORPORATION 21.3.6.1. Overview 21.3.6.2. Product Portfolio 21.3.6.3. Sales Footprint 21.3.6.4. Strategy Overview 21.3.7. LIVANOVA PLC 21.3.7.1. Overview 21.3.7.2. Product Portfolio 21.3.7.3. Sales Footprint 21.3.7.4. Strategy Overview 21.3.8. EUROSETS S.R.L 21.3.8.1. Overview 21.3.8.2. Product Portfolio 21.3.8.3. Sales Footprint 21.3.8.4. Strategy Overview 21.3.9. ORIGEN BIOMEDICAL, INC 21.3.9.1. Overview 21.3.9.2. Product Portfolio 21.3.9.3. Sales Footprint 21.3.9.4. Strategy Overview 21.3.10. CYTOSORBENTS CORPORATION 21.3.10.1. Overview 21.3.10.2. Product Portfolio 21.3.10.3. Sales Footprint 21.3.10.4. Strategy Overview 22. Assumptions and Acronyms Used 23. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ Million), By Provider, 2015 to 2021 Table 2: Global Market Value (US$ Million), By Provider, 2022 to 2032 Table 3: Global Market Value (US$ Million), By Component, 2015 to 2021 Table 4: Global Market Value (US$ Million), By Component, 2022 to 2032 Table 5: Global Market Value (US$ Million), By Product, 2015 to 2021 Table 6: Global Market Value (US$ Million), By Product, 2022 to 2032 Table 7: Global Market Value (US$ Million), By Patient Type, 2015 to 2021 Table 8: Global Market Value (US$ Million), By Patient Type, 2022 to 2032 Table 9: Global Market Value (US$ Million), By Modality, 2015 to 2021 Table 10: Global Market Value (US$ Million), By Modality, 2022 to 2032 Table 11: Global Market, By Region, 2015 to 2021 Table 12: Global Market, By Region, 2022 to 2032 Table 13: North America Market Value (US$ Million), By Provider, 2015 to 2021 Table 14: North America Market Value (US$ Million), By Provider, 2022 to 2032 Table 15: North America Market Value (US$ Million), By Component, 2015 to 2021 Table 16: North America Market Value (US$ Million), By Component, 2022 to 2032 Table 17: North America Market Value (US$ Million), By Product, 2015 to 2021 Table 18: North America Market Value (US$ Million), By Product, 2022 to 2032 Table 19: North America Market Value (US$ Million), By Patient Type, 2015 to 2021 Table 20: North America Market Value (US$ Million), By Patient Type, 2022 to 2032 Table 21: North America Market Value (US$ Million), By Modality, 2015 to 2021 Table 22: North America Market Value (US$ Million), By Modality, 2022 to 2032 Table 23: North America Market, By Country, 2015 to 2021 Table 24: North America Market, By Country, 2022 to 2032 Table 25: Latin America Market Value (US$ Million), By Provider, 2015 to 2021 Table 26: Latin America Market Value (US$ Million), By Provider, 2022 to 2032 Table 27: Latin America Market Value (US$ Million), By Component, 2015 to 2021 Table 28: Latin America Market Value (US$ Million), By Component, 2022 to 2032 Table 29: Latin America Market Value (US$ Million), By Product, 2015 to 2021 Table 30: Latin America Market Value (US$ Million), By Product, 2022 to 2032 Table 31: Latin America Market Value (US$ Million), By Patient Type, 2015 to 2021 Table 32: Latin America Market Value (US$ Million), By Patient Type, 2022 to 2032 Table 33: Latin America Market Value (US$ Million), By Modality, 2015 to 2021 Table 34: Latin America Market Value (US$ Million), By Modality, 2022 to 2032 Table 35: Latin America Market, By Country, 2015 to 2021 Table 36: Latin America Market, By Country, 2022 to 2032 Table 37: Europe Market Value (US$ Million), By Provider, 2015 to 2021 Table 38: Europe Market Value (US$ Million), By Provider, 2022 to 2032 Table 39: Europe Market Value (US$ Million), By Component, 2015 to 2021 Table 40: Europe Market Value (US$ Million), By Component, 2022 to 2032 Table 41: Europe Market Value (US$ Million), By Product, 2015 to 2021 Table 42: Europe Market Value (US$ Million), By Product, 2022 to 2032 Table 43: Europe Market Value (US$ Million), By Patient Type, 2015 to 2021 Table 44: Europe Market Value (US$ Million), By Patient Type, 2022 to 2032 Table 45: Europe Market Value (US$ Million), By Modality, 2015 to 2021 Table 46: Europe Market Value (US$ Million), By Modality, 2022 to 2032 Table 47: Europe Market, By Country, 2015 to 2021 Table 48: Europe Market, By Country, 2022 to 2032 Table 49: Asia Pacific Market Value (US$ Million), By Provider, 2015 to 2021 Table 50: Asia Pacific Market Value (US$ Million), By Provider, 2022 to 2032 Table 51: Asia Pacific Market Value (US$ Million), By Component, 2015 to 2021 Table 52: Asia Pacific Market Value (US$ Million), By Component, 2022 to 2032 Table 53: Asia Pacific Market Value (US$ Million), By Product, 2015 to 2021 Table 54: Asia Pacific Market Value (US$ Million), By Product, 2022 to 2032 Table 55: Asia Pacific Market Value (US$ Million), By Patient Type, 2015 to 2021 Table 56: Asia Pacific Market Value (US$ Million), By Patient Type, 2022 to 2032 Table 57: Asia Pacific Market Value (US$ Million), By Modality, 2015 to 2021 Table 58: Asia Pacific Market Value (US$ Million), By Modality, 2022 to 2032 Table 59: Asia Pacific Market, By Country, 2015 to 2021 Table 60: Asia Pacific Market, By Country, 2022 to 2032 Table 61: MEA Market Value (US$ Million), By Provider, 2015 to 2021 Table 62: MEA Market Value (US$ Million), By Provider, 2022 to 2032 Table 63: MEA Market Value (US$ Million), By Component, 2015 to 2021 Table 64: MEA Market Value (US$ Million), By Component, 2022 to 2032 Table 65: MEA Market Value (US$ Million), By Product, 2015 to 2021 Table 66: MEA Market Value (US$ Million), By Product, 2022 to 2032 Table 67: MEA Market Value (US$ Million), By Patient Type, 2015 to 2021 Table 68: MEA Market Value (US$ Million), By Patient Type, 2022 to 2032 Table 69: MEA Market Value (US$ Million), By Modality, 2015 to 2021 Table 70: MEA Market Value (US$ Million), By Modality, 2022 to 2032 Table 71: MEA Market, By Country, 2015 to 2021 Table 72: MEA Market, By Country, 2022 to 2032
Figure 1: Global Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032 Figure 2: Global Market Absolute $ Historical Gain (2015 to 2021) and Opportunity (2022 to 2032), US$ Million Figure 3: Global Market Share, By Provider, 2022 & 2032 Figure 4: Global Market Y-o-Y Growth Projections, By Provider – 2022 to 2032 Figure 5: Global Market Attractiveness Index, By Provider – 2022 to 2032 Figure 6: Global Market Share, By Component, 2022 & 2032 Figure 7: Global Market Y-o-Y Growth Projections, By Component – 2022 to 2032 Figure 8: Global Market Attractiveness Index, By Component – 2022 to 2032 Figure 9: Global Market Share, By Patient Type, 2022 & 2032 Figure 10: Global Market Y-o-Y Growth Projections, By Patient Type – 2022 to 2032 Figure 11: Global Market Attractiveness Index, By Patient Type – 2022 to 2032 Figure 12: Global Market Share, By Product, 2022 & 2032 Figure 13: Global Market Y-o-Y Growth Projections, By Product – 2022 to 2032 Figure 14: Global Market Attractiveness Index, By Product – 2022 to 2032 Figure 15: Global Market Share, By Modality, 2022 & 2032 Figure 16: Global Market Y-o-Y Growth Projections, By Modality – 2022 to 2032 Figure 17: Global Market Attractiveness Index, By Modality – 2022 to 2032 Figure 18: Global Market Share, By Region, 2022 & 2032 Figure 19: Global Market Y-o-Y Growth Projections, By Region – 2022 to 2032 Figure 20: Global Market Attractiveness Index, By Region – 2022 to 2032 Figure 21: North America Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032 Figure 22: North America Market Absolute $ Historical Gain (2015 to 2021) and Opportunity (2022 to 2032), US$ Million Figure 23: North America Market Share, By Provider, 2022 & 2032 Figure 24: North America Market Y-o-Y Growth Projections, By Provider – 2022 to 2032 Figure 25: North America Market Attractiveness Index, By Provider – 2022 to 2032 Figure 26: North America Market Share, By Component, 2022 & 2032 Figure 27: North America Market Y-o-Y Growth Projections, By Component – 2022 to 2032 Figure 28: North America Market Attractiveness Index, By Component – 2022 to 2032 Figure 29: North America Market Share, By Patient Type, 2022 & 2032 Figure 30: North America Market Y-o-Y Growth Projections, By Patient Type – 2022 to 2032 Figure 31: North America Market Attractiveness Index, By Patient Type – 2022 to 2032 Figure 32: North America Market Share, By Product, 2022 & 2032 Figure 33: North America Market Y-o-Y Growth Projections, By Product – 2022 to 2032 Figure 34: North America Market Attractiveness Index, By Product – 2022 to 2032 Figure 35: North America Market Share, By Modality, 2022 & 2032 Figure 36: North America Market Y-o-Y Growth Projections, By Modality – 2022 to 2032 Figure 37: North America Market Attractiveness Index, By Modality – 2022 to 2032 Figure 38: North America Market Share, By Country, 2022 & 2032 Figure 39: North America Market Y-o-Y Growth Projections, By Country – 2022 to 2032 Figure 40: North America Market Attractiveness Index, By Country – 2022 to 2032 Figure 41: Latin America Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032 Figure 42: Latin America Market Absolute $ Historical Gain (2015 to 2021) and Opportunity (2022 to 2032), US$ Million Figure 43: Latin America Market Share, By Provider, 2022 & 2032 Figure 44: Latin America Market Y-o-Y Growth Projections, By Provider – 2022 to 2032 Figure 45: Latin America Market Attractiveness Index, By Provider – 2022 to 2032 Figure 46: Latin America Market Share, By Component, 2022 & 2032 Figure 47: Latin America Market Y-o-Y Growth Projections, By Component – 2022 to 2032 Figure 48: Latin America Market Attractiveness Index, By Component – 2022 to 2032 Figure 49: Latin America Market Share, By Patient Type, 2022 & 2032 Figure 50: Latin America Market Y-o-Y Growth Projections, By Patient Type – 2022 to 2032 Figure 51: Latin America Market Attractiveness Index, By Patient Type – 2022 to 2032 Figure 52: Latin America Market Share, By Product, 2022 & 2032 Figure 53: Latin America Market Y-o-Y Growth Projections, By Product – 2022 to 2032 Figure 54: Latin America Market Attractiveness Index, By Product – 2022 to 2032 Figure 55: Latin America Market Share, By Modality, 2022 & 2032 Figure 56: Latin America Market Y-o-Y Growth Projections, By Modality – 2022 to 2032 Figure 57: Latin America Market Attractiveness Index, By Modality – 2022 to 2032 Figure 58: Latin America Market Share, By Country, 2022 & 2032 Figure 59: Latin America Market Y-o-Y Growth Projections, By Country – 2022 to 2032 Figure 60: Latin America Market Attractiveness Index, By Country – 2022 to 2032 Figure 61: Europe Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032 Figure 62: Europe Market Absolute $ Historical Gain (2015 to 2021) and Opportunity (2022 to 2032), US$ Million Figure 63: Europe Market Share, By Provider, 2022 & 2032 Figure 64: Europe Market Y-o-Y Growth Projections, By Provider – 2022 to 2032 Figure 65: Europe Market Attractiveness Index, By Provider – 2022 to 2032 Figure 66: Europe Market Share, By Component, 2022 & 2032 Figure 67: Europe Market Y-o-Y Growth Projections, By Component – 2022 to 2032 Figure 68: Europe Market Attractiveness Index, By Component – 2022 to 2032 Figure 69: Europe Market Share, By Patient Type, 2022 & 2032 Figure 70: Europe Market Y-o-Y Growth Projections, By Patient Type – 2022 to 2032 Figure 71: Europe Market Attractiveness Index, By Patient Type – 2022 to 2032 Figure 72: Europe Market Share, By Product, 2022 & 2032 Figure 73: Europe Market Y-o-Y Growth Projections, By Product – 2022 to 2032 Figure 74: Europe Market Attractiveness Index, By Product – 2022 to 2032 Figure 75: Europe Market Share, By Modality, 2022 & 2032 Figure 76: Europe Market Y-o-Y Growth Projections, By Modality – 2022 to 2032 Figure 77: Europe Market Attractiveness Index, By Modality – 2022 to 2032 Figure 78: Europe Market Share, By Country, 2022 & 2032 Figure 79: Europe Market Y-o-Y Growth Projections, By Country – 2022 to 2032 Figure 80: Europe Market Attractiveness Index, By Country – 2022 to 2032 Figure 81: Asia Pacific Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032 Figure 82: Asia Pacific Market Absolute $ Historical Gain (2015 to 2021) and Opportunity (2022 to 2032), US$ Million Figure 83: Asia Pacific Market Share, By Provider, 2022 & 2032 Figure 84: Asia Pacific Market Y-o-Y Growth Projections, By Provider – 2022 to 2032 Figure 85: Asia Pacific Market Attractiveness Index, By Provider – 2022 to 2032 Figure 86: Asia Pacific Market Share, By Component, 2022 & 2032 Figure 87: Asia Pacific Market Y-o-Y Growth Projections, By Component – 2022 to 2032 Figure 88: Asia Pacific Market Attractiveness Index, By Component – 2022 to 2032 Figure 89: Asia Pacific Market Share, By Patient Type, 2022 & 2032 Figure 90: Asia Pacific Market Y-o-Y Growth Projections, By Patient Type – 2022 to 2032 Figure 91: Asia Pacific Market Attractiveness Index, By Patient Type – 2022 to 2032 Figure 92: Asia Pacific Market Share, By Product, 2022 & 2032 Figure 93: Asia Pacific Market Y-o-Y Growth Projections, By Product – 2022 to 2032 Figure 94: Asia Pacific Market Attractiveness Index, By Product – 2022 to 2032 Figure 95: Asia Pacific Market Share, By Modality, 2022 & 2032 Figure 96: Asia Pacific Market Y-o-Y Growth Projections, By Modality – 2022 to 2032 Figure 97: Asia Pacific Market Attractiveness Index, By Modality – 2022 to 2032 Figure 98: Asia Pacific Market Share, By Country, 2022 & 2032 Figure 99: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022 to 2032 Figure 100: Asia Pacific Market Attractiveness Index, By Country – 2022 to 2032 Figure 101: MEA Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032 Figure 102: MEA Market Absolute $ Historical Gain (2015 to 2021) and Opportunity (2022 to 2032), US$ Million Figure 103: MEA Market Share, By Provider, 2022 & 2032 Figure 104: MEA Market Y-o-Y Growth Projections, By Provider – 2022 to 2032 Figure 105: MEA Market Attractiveness Index, By Provider – 2022 to 2032 Figure 106: MEA Market Share, By Component, 2022 & 2032 Figure 107: MEA Market Y-o-Y Growth Projections, By Component – 2022 to 2032 Figure 108: MEA Market Attractiveness Index, By Component – 2022 to 2032 Figure 109: MEA Market Share, By Patient Type, 2022 & 2032 Figure 110: MEA Market Y-o-Y Growth Projections, By Patient Type – 2022 to 2032 Figure 111: MEA Market Attractiveness Index, By Patient Type – 2022 to 2032 Figure 112: MEA Market Share, By Product, 2022 & 2032 Figure 113: MEA Market Y-o-Y Growth Projections, By Product – 2022 to 2032 Figure 114: MEA Market Attractiveness Index, By Product – 2022 to 2032 Figure 115: MEA Market Share, By Modality, 2022 & 2032 Figure 116: MEA Market Y-o-Y Growth Projections, By Modality – 2022 to 2032 Figure 117: MEA Market Attractiveness Index, By Modality – 2022 to 2032 Figure 118: MEA Market Share, By Country, 2022 & 2032 Figure 119: MEA Market Y-o-Y Growth Projections, By Country – 2022 to 2032 Figure 120: MEA Market Attractiveness Index, By Country – 2022 to 2032
Recommendations
Explore Healthcare Insights
View Reports